Table 3. All-ages, age-specific and age-standardised 3-year net survival (%) with 95% CI, by stage at diagnosis and country for women diagnosed with breast cancer during 2000-2007.
|
Australiaa |
Canadab |
Denmarkc |
Norway |
Swedend |
UKe |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | |||||||
|
TNM stage | ||||||||||||||||||
|
All patients | ||||||||||||||||||
| All ages | 92.4 | 92.0 | 92.9 | 89.0 | 88.2 | 89.8 | 90.6 | 90.1 | 91.1 | 94.3 | 93.8 | 94.8 | 87.3 | 87.1 | 87.5 | |||
| Age-standardised | 92.4 | 92.0 | 92.7 | 89.0 | 88.4 | 89.6 | 90.5 | 90.1 | 90.9 | 94.1 | 93.8 | 94.5 | 87.4 | 87.3 | 87.6 | |||
| 15–49 | 93.4 | 92.8 | 94.0 | 93.1 | 92.1 | 94.2 | 92.8 | 92.1 | 93.5 | 95.5 | 94.9 | 96.1 | 91.1 | 90.8 | 91.4 | |||
| 50–69 | 94.1 | 93.7 | 94.6 | 91.5 | 90.8 | 92.3 | 93.8 | 93.4 | 94.2 | 95.7 | 95.3 | 96.1 | 91.6 | 91.4 | 91.8 | |||
| 70–99 |
|
|
|
89.2 |
88.2 |
90.3 |
82.5 |
80.7 |
84.4 |
83.5 |
82.1 |
84.8 |
90.9 |
89.7 |
92.2 |
78.6 |
78.1 |
79.1 |
|
Stage I | ||||||||||||||||||
| All ages | 99.7 | 99.5 | 99.8 | 99.4 | 98.9 | 99.8 | 99.5 | 99.3 | 99.8 | 99.3 | 99.0 | 99.6 | 99.3 | 99.2 | 99.4 | |||
| Age-standardised | 99.7 | 99.6 | 99.7 | 99.4 | 99.1 | 99.6 | 99.5 | 99.4 | 99.7 | 99.3 | 99.1 | 99.4 | 99.3 | 99.2 | 99.4 | |||
| 15–49 | 99.3 | 98.9 | 99.7 | 98.6 | 97.6 | 99.7 | 99.0 | 98.6 | 99.5 | 98.5 | 97.9 | 99.1 | 98.5 | 98.2 | 98.8 | |||
| 50–69 | 99.7 | 99.5 | 99.9 | 99.4 | 99.0 | 99.9 | 99.6 | 99.3 | 99.8 | 99.4 | 99.1 | 99.6 | 99.4 | 99.2 | 99.5 | |||
| 70–99 |
|
|
|
99.9 |
99.8 |
100.0 |
99.8 |
99.5 |
100.0 |
99.8 |
99.7 |
99.9 |
99.7 |
99.6 |
99.9 |
99.7 |
99.6 |
99.9 |
|
Stage II | ||||||||||||||||||
| All ages | 96.4 | NA | NA | 95.5 | 94.4 | 96.6 | 91.5 | 90.7 | 92.3 | 94.1 | 93.3 | 94.8 | 92.4 | 92.1 | 92.8 | |||
| Age-standardised | 96.4 | 96.0 | 96.8 | 95.3 | 94.4 | 96.2 | 91.4 | 90.8 | 92.0 | 94.1 | 93.6 | 94.6 | 92.4 | 92.2 | 92.7 | |||
| 15–49 | 96.0 | 95.2 | 96.7 | 95.5 | 94.1 | 96.9 | 92.7 | 91.8 | 93.7 | 94.9 | 94.0 | 95.8 | 92.4 | 92.0 | 92.9 | |||
| 50–69 | 96.2 | 95.5 | 96.9 | 96.8 | 95.8 | 97.7 | 93.4 | 92.6 | 94.1 | 94.7 | 94.0 | 95.5 | 93.1 | 92.8 | 93.5 | |||
| 70–99 |
|
|
|
97.2 |
95.8 |
98.7 |
93.2 |
90.0 |
96.3 |
87.1 |
84.8 |
89.3 |
92.5 |
90.8 |
94.2 |
91.2 |
90.4 |
92.1 |
|
Stage III | ||||||||||||||||||
| All ages | 83.1 | 81.2 | 84.9 | 82.7 | 80.2 | 85.1 | 79.2 | 75.6 | 82.9 | 76.2 | 72.8 | 79.7 | 70.2 | 69.0 | 71.4 | |||
| Age-standardised | 82.0 | 81.1 | 82.9 | 81.9 | 80.7 | 83.0 | 80.7 | 79.2 | 82.2 | 77.3 | 75.8 | 78.8 | 70.7 | 69.9 | 71.5 | |||
| 15–49 | 85.8 | 84.1 | 87.5 | 85.7 | 83.5 | 87.9 | 84.6 | 81.6 | 87.6 | 81.7 | 78.8 | 84.7 | 76.5 | 74.8 | 78.1 | |||
| 50–69 | 84.9 | 83.2 | 86.6 | 84.4 | 82.1 | 86.7 | 83.4 | 80.3 | 86.5 | 80.7 | 77.8 | 83.7 | 74.6 | 73.3 | 76.0 | |||
| 70–99 |
|
|
|
76.2 |
73.4 |
79.0 |
76.5 |
73.1 |
79.9 |
73.8 |
69.2 |
78.5 |
69.7 |
65.3 |
74.1 |
61.9 |
59.9 |
63.9 |
|
Stage IV | ||||||||||||||||||
| All ages | 39.9 | 36.9 | 42.8 | 35.6 | 31.7 | 39.5 | 31.6 | 28.7 | 34.5 | 41.8 | 37.3 | 46.2 | 27.4 | 26.1 | 28.8 | |||
| Age-standardised | 37.8 | 35.6 | 40.1 | 36.1 | 33.4 | 38.8 | 31.6 | 29.6 | 33.7 | 41.8 | 38.6 | 45.0 | 27.9 | 26.9 | 28.9 | |||
| 15–49 | 55.4 | 49.7 | 61.0 | 54.3 | 44.4 | 64.1 | 34.9 | 29.0 | 40.8 | 64.8 | 56.1 | 73.5 | 36.2 | 33.1 | 39.4 | |||
| 50–69 | 39.6 | 35.8 | 43.4 | 40.4 | 35.4 | 45.3 | 37.4 | 33.5 | 41.4 | 41.6 | 35.7 | 47.5 | 33.1 | 31.2 | 35.0 | |||
| 70–99 |
|
|
|
31.5 |
26.6 |
36.3 |
26.5 |
21.6 |
31.5 |
25.5 |
21.5 |
29.5 |
34.2 |
27.5 |
40.9 |
20.8 |
19.0 |
22.6 |
|
Missing stage | ||||||||||||||||||
| All ages | 85.9 | 84.7 | 87.1 | 74.5 | 71.2 | 77.9 | 85.6 | 83.7 | 87.6 | 94.3 | 93.1 | 95.5 | 77.0 | 76.5 | 77.6 | |||
| Age-standardised | 85.8 | 84.9 | 86.7 | 76.2 | 74.1 | 78.4 | 87.3 | 86.1 | 88.5 | 92.3 | 91.0 | 93.7 | 77.1 | 76.7 | 77.5 | |||
| 15–49 | 93.0 | 91.6 | 94.4 | 88.7 | 83.0 | 94.4 | 95.0 | 93.1 | 96.8 | 96.8 | 95.4 | 98.3 | 88.0 | 87.2 | 88.7 | |||
| 50–69 | 90.7 | 89.6 | 91.8 | 76.4 | 72.2 | 80.6 | 92.9 | 91.5 | 94.4 | 97.5 | 96.8 | 98.2 | 85.7 | 85.2 | 86.3 | |||
| 70–99 |
|
|
|
80.1 |
78.1 |
82.1 |
71.9 |
67.4 |
76.3 |
79.5 |
76.3 |
82.7 |
87.2 |
83.8 |
90.6 |
66.9 |
66.0 |
67.9 |
|
SEER Summary Stage 2000 | ||||||||||||||||||
|
All patients | ||||||||||||||||||
| All ages | 92.5 | 92.2 | 92.9 | 92.4 | 92.0 | 92.8 | 89.0 | 88.3 | 89.8 | 90.6 | 90.0 | 91.1 | 94.3 | 93.8 | 94.8 | 86.1 | 85.6 | 86.7 |
| Age-standardised | 92.2 | 91.9 | 92.5 | 92.5 | 92.1 | 92.8 | 89.2 | 88.7 | 89.8 | 90.7 | 90.3 | 91.1 | 94.2 | 93.9 | 94.6 | 86.6 | 86.3 | 87.0 |
| 15–49 | 93.7 | 93.2 | 94.2 | 93.4 | 92.9 | 94.0 | 93.2 | 92.1 | 94.2 | 92.9 | 92.2 | 93.6 | 95.5 | 94.9 | 96.1 | 90.6 | 89.9 | 91.3 |
| 50–69 | 94.4 | 94.1 | 94.8 | 94.1 | 93.7 | 94.5 | 91.5 | 90.8 | 92.3 | 93.7 | 93.3 | 94.2 | 95.7 | 95.3 | 96.1 | 90.6 | 90.1 | 91.1 |
| 70–99 |
88.0 |
87.0 |
89.0 |
89.2 |
88.2 |
90.3 |
82.6 |
80.8 |
84.4 |
83.5 |
82.1 |
84.9 |
90.9 |
89.7 |
92.2 |
77.2 |
76.0 |
78.4 |
|
Localised | ||||||||||||||||||
| All ages | 98.8 | 98.3 | 99.1 | 99.4 | 99.1 | 99.6 | 98.9 | 98.4 | 99.5 | 98.7 | NA | NA | 98.3 | 97.9 | 98.7 | 98.5 | 98.2 | 98.9 |
| Age-standardised | 98.7 | 98.5 | 99.0 | 99.3 | 99.2 | 99.5 | 98.9 | 98.6 | 99.2 | 98.7 | 98.4 | 99.0 | 98.3 | 98.0 | 98.5 | 98.6 | 98.3 | 98.8 |
| 15–49 | 98.2 | 97.7 | 98.6 | 98.7 | 98.2 | 99.1 | 98.4 | 97.4 | 99.4 | 98.3 | 97.7 | 98.9 | 97.7 | 97.2 | 98.3 | 96.9 | 96.2 | 97.7 |
| 50–69 | 98.9 | 98.6 | 99.2 | 99.3 | 99.0 | 99.6 | 98.6 | 97.8 | 99.5 | 99.0 | 98.7 | 99.4 | 98.2 | 97.8 | 98.6 | 98.5 | 98.1 | 99.0 |
| 70–99 |
98.8 |
97.5 |
100.0 |
100.0 |
99.9 |
100.0 |
99.8 |
99.4 |
100.0 |
98.3 |
96.8 |
99.7 |
98.8 |
97.8 |
99.7 |
99.8 |
99.3 |
100.0 |
|
Regional | ||||||||||||||||||
| All ages | 91.6 | 90.9 | 92.3 | 91.2 | 90.3 | 92.1 | 91.2 | 90.0 | 92.4 | 88.6 | 87.7 | 89.6 | 88.0 | 86.8 | 89.3 | 87.2 | 86.1 | 88.2 |
| Age-standardised | 91.4 | 90.9 | 91.9 | 91.1 | 90.5 | 91.8 | 91.1 | 90.3 | 92.0 | 89.0 | 88.3 | 89.6 | 89.0 | 88.2 | 89.8 | 87.2 | 86.5 | 88.0 |
| 15–49 | 92.2 | 91.3 | 93.0 | 91.8 | 90.7 | 92.9 | 92.5 | 91.0 | 94.1 | 91.7 | 90.6 | 92.9 | 92.0 | 90.5 | 93.5 | 89.3 | 88.0 | 90.7 |
| 50–69 | 92.9 | 92.2 | 93.6 | 92.9 | 92.0 | 93.8 | 92.4 | 91.3 | 93.6 | 91.7 | 90.8 | 92.6 | 91.2 | 90.1 | 92.4 | 88.5 | 87.4 | 89.6 |
| 70–99 |
87.8 |
85.9 |
89.7 |
87.0 |
84.5 |
89.5 |
87.1 |
83.9 |
90.4 |
79.8 |
77.1 |
82.4 |
80.5 |
77.6 |
83.4 |
82.5 |
79.9 |
85.0 |
|
Distant | ||||||||||||||||||
| All ages | 53.7 | 51.4 | 56.0 | 39.7 | 36.8 | 42.7 | 35.3 | 31.5 | 39.2 | 31.4 | 28.6 | 34.3 | 41.7 | 37.2 | 46.1 | 54.8 | 49.1 | 60.6 |
| Age-standardised | 52.0 | 50.3 | 53.6 | 38.6 | 36.4 | 40.8 | 37.2 | 34.4 | 39.9 | 32.3 | 30.2 | 34.3 | 42.9 | 39.7 | 46.1 | 54.8 | 50.3 | 59.2 |
| 15–49 | 71.3 | 67.2 | 75.3 | 55.2 | 49.5 | 60.9 | 54.2 | 44.4 | 64.1 | 34.9 | 29.0 | 40.8 | 64.9 | 56.2 | 73.5 | 65.8 | 52.5 | 79.2 |
| 50–69 | 60.8 | 57.9 | 63.8 | 39.8 | 36.0 | 43.6 | 40.8 | 35.8 | 45.7 | 37.8 | 33.8 | 41.8 | 41.9 | 36.0 | 47.8 | 62.5 | 55.6 | 69.4 |
| 70–99 |
34.5 |
30.8 |
38.3 |
30.8 |
26.0 |
35.6 |
25.6 |
20.7 |
30.4 |
24.9 |
21.0 |
28.8 |
33.6 |
27.0 |
40.3 |
41.9 |
32.6 |
51.2 |
|
Missing stage | ||||||||||||||||||
| All ages | 80.6 | 78.7 | 82.5 | 85.6 | 84.4 | 86.7 | 74.3 | 71.0 | 77.6 | 85.2 | 83.3 | 87.2 | 94.1 | 92.9 | 95.4 | 71.2 | 70.0 | 72.3 |
| Age-standardised | 80.6 | 79.1 | 82.0 | 85.2 | 84.2 | 86.1 | 75.9 | 73.7 | 78.1 | 86.7 | 85.4 | 88.0 | 92.1 | 90.7 | 93.5 | 71.3 | 70.4 | 72.1 |
| 15–49 | 88.1 | 85.6 | 90.7 | 92.9 | 91.5 | 94.3 | 89.5 | 84.0 | 95.0 | 94.8 | 92.9 | 96.7 | 96.9 | 95.4 | 98.4 | 83.8 | 82.1 | 85.5 |
| 50–69 | 87.3 | 85.5 | 89.2 | 90.5 | 89.3 | 91.6 | 76.3 | 72.1 | 80.6 | 92.7 | 91.2 | 94.2 | 97.4 | 96.7 | 98.1 | 79.6 | 78.4 | 80.9 |
| 70–99 | 73.0 | 69.6 | 76.4 | 79.6 | 77.5 | 81.7 | 71.5 | 67.0 | 76.0 | 79.0 | 75.8 | 82.2 | 86.9 | 83.5 | 90.4 | 61.5 | 59.7 | 63.3 |
Abbreviations: CI=confidence interval; NA=not available; NS=net survival; TNM=Tumour, Nodes, Metastasis staging system.
a
Australia: New South Wales
b
Canada: British Columbia and Manitoba.
c
In Denmark we analysed women diagnosed during 2004–7.
d
Sweden: Uppsala-Örebro and Stockholm-Gotland health regions.
e
United Kingdom (TNM analysis): Northern Ireland, Wales and the Northern and Yorkshire Cancer Registry and Information Service, Eastern Cancer Registration and Information Centre, Oxford Cancer Intelligence Unit, West Midlands Cancer Intelligence Unit in England; United Kingdom (SEER analysis): Northern Ireland and Wales.